Search

everythinglearnresearchcommunity

for

Search:↓

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Alopecia areata is caused by the immune system attacking hair follicles.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Reducing CD8+ T cell growth can stabilize alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.